Territory Development Plan. Except for the activities allocated to Zai under the Global Development Plan pursuant to Section 5.3, all Development by Zai of Licensed Products in the Territory under this Agreement shall be conducted pursuant to a written development plan (as amended from time to time in accordance with this Section 5.4 and Section 3.2, the “Territory Development Plan”), which Territory Development Plan shall CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED WITH [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. contain in reasonable detail all major Development activities (including all Clinical Trials) for Licensed Products in the Territory and the timelines for achieving such activities. Attached hereto as Exhibit C is an initial draft of the Territory Development Plan and attached hereto as Exhibit B is a NMPA Submission Timeline for the indications of recurrent and newly diagnosed GBM. From time to time as needed thereafter, Zai shall propose amendments to the Territory Development Plan in consultation with NVCR and submit such proposed updated or amended Territory Development Plan to the JSC for review, discussion and approval. Once approved by the JSC, the amended Territory Development Plan shall become effective. For clarity, the Territory Development Plan and amendments thereto must be consistent with the Global Development Plan and the Global Development Plan shall take precedent in case of any conflict or inconsistency between the Territory Development Plan and the Global Development Plan.
Appears in 1 contract
Territory Development Plan. Except for the activities allocated to Zai BeiGene under the Global Development Plan pursuant to Section 5.35.2, all Development by Zai of Licensed Products in the Territory under this Agreement shall be conducted by BeiGene pursuant to a written development plan (as amended from time to time in accordance with this Section 5.4 5.3 and Section 3.23.3(a), the “Territory Development Plan”” and, until the Territory Development Plan is approved pursuant to this Section 5.3(a), which all references in this Agreement to the Territory Development Plan shall CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED WITH [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSEDbe deemed references to the ABI-H0731 Initial Development Plan). contain in reasonable detail all major The Territory Development Plan shall include a proposed budget for the Development activities (including all the Territory Clinical Trials) for Licensed Products in set forth under the Territory and Development Plan (including any Costs incurred related to any start-up activities for any Phase 3 Clinical Trial) (the timelines for achieving such activities“Territory Development Budget”). Attached hereto as Exhibit C is an AssemblyBio will propose the initial draft of the Territory Development Plan and attached hereto as Exhibit B is a NMPA Submission Timeline for the indications of recurrent Licensed ABI-H2158 Products and newly diagnosed GBMLicensed ABI-H3733 Products and submit to the JDC for its review, discussion and approval. From time to time as needed thereafterafter the Effective Date, Zai shall but not less than annually, either Party may propose amendments to the Territory Development Plan in consultation with NVCR and submit such proposed updated or amended Territory Development Plan to the JSC JDC for review, discussion and approval. Once approved by the JSCJDC, the amended Territory Development Plan shall become effective. For clarity, the Territory Development Plan and amendments thereto must shall be consistent with the Global Development Plan Plan, and the Global Development Plan shall take precedent precedence in case of any conflict or inconsistency between the Territory Development Plan and the Global Development Plan.
Appears in 1 contract
Samples: Collaboration Agreement (Assembly Biosciences, Inc.)
Territory Development Plan. Except for the activities allocated to Zai under the Global Development Plan pursuant to Section 5.3, all Development by Zai of Licensed Products in the Territory under this Agreement shall be conducted pursuant to a written development plan (as amended from time to time in accordance with this Section 5.4 and Section 3.2, the “Territory Development Plan”), which Territory Development Plan shall CERTAIN THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***], ] AND HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL FILED SEPARATELY WITH THE SECURITIES AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSEDEXCHANGE COMMISSION. 19 contain in reasonable detail all major Development activities (including all Clinical Trials) for Licensed Products in the Territory and the timelines for achieving such activities. Attached hereto as Exhibit C is an initial draft of the Territory Development Plan and attached hereto as Exhibit B is a NMPA Submission Timeline for the indications of recurrent and newly diagnosed GBM. From time to time as needed thereafter, Zai shall propose amendments to the Territory Development Plan in consultation with NVCR and submit such proposed updated or amended Territory Development Plan to the JSC for review, discussion and approval. Once approved by the JSC, the amended Territory Development Plan shall become effective. For clarity, the Territory Development Plan and amendments thereto must be consistent with the Global Development Plan and the Global Development Plan shall take precedent in case of any conflict or inconsistency between the Territory Development Plan and the Global Development Plan.
Appears in 1 contract